Protective protein/cathepsin A loss in cultured cells derived from an early-infantile form of galactosialidosis patients homozygous for the A1184-G transition (Y395C mutation)

被引:6
作者
Itoh, K
Shimmoto, M
Utsumi, K
Mizoguchi, N
Miharu, N
Ohama, E
Sakuraba, H
机构
[1] Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Bunkyo Ku, Tokyo 1138613, Japan
[2] Hiroshima Univ, Sch Med, Dept Pediat, Minami Ku, Hiroshima 7340037, Japan
[3] Hiroshima Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, Hiroshima 7340037, Japan
关键词
D O I
10.1006/bbrc.1998.8659
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Galactosialidosis is a human autosomal recessive lysosomal storage disease caused by a genetic defect of protective protein/cathepsin A (PPCA). The patients in a Japanese family with the severe early-infantile form of galactosialidosis were revealed to be homozygous for the A1184-G transition in the PPCA gene in both alleles, which leads to the Y395C substitution The acid carboxypeptidase (cathepsin A) and lysosomal neuraminidase activities were markedly decreased in cultured fibroblasts and chorionic villus cells derived from the patients, although the decrease in beta-galactosidase activity was less. Immunoblot and immunocytochemical analyses showed that neither the precursor nor the mature form of the PPCA gene product was present in the cultured cells, The Y395C mutation was revealed to cause the loss of the translated product, that determines the severity of the clinical phenotype. (C) 1998 Academic Press.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 23 条
[1]   Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis [J].
Bonten, E ;
vanderSpoel, A ;
Fornerod, M ;
Grosveld, G ;
dAzzo, A .
GENES & DEVELOPMENT, 1996, 10 (24) :3156-3169
[2]  
BONTEN EJ, 1995, J BIOL CHEM, V270, P26442
[3]   Protein processing: A role in the pathophysiology of genetic disease [J].
Brooks, DA .
FEBS LETTERS, 1997, 409 (02) :115-120
[4]   MOLECULAR DEFECT IN COMBINED BETA-GALACTOSIDASE AND NEURAMINIDASE DEFICIENCY IN MAN [J].
DAZZO, A ;
HOOGEVEEN, A ;
REUSER, AJJ ;
ROBINSON, D ;
GALJAARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (15) :4535-4539
[5]  
DAZZO A, 1995, METABOLIC MOL BASES, P2825
[6]   EXPRESSION OF CDNA-ENCODING THE HUMAN PROTECTIVE PROTEIN ASSOCIATED WITH LYSOSOMAL BETA-GALACTOSIDASE AND NEURAMINIDASE - HOMOLOGY TO YEAST PROTEASES [J].
GALJART, NJ ;
GILLEMANS, N ;
HARRIS, A ;
VANDERHORST, GTJ ;
VERHEIJEN, FW ;
GALJAARD, H ;
DAZZO, A .
CELL, 1988, 54 (06) :755-764
[7]  
GALJART NJ, 1991, J BIOL CHEM, V266, P14754
[8]   PROTECTIVE PROTEIN AS AN ENDOGENOUS ENDOTHELIN DEGRADATION ENZYME IN HUMAN TISSUES [J].
ITOH, K ;
KASE, R ;
SHIMMOTO, M ;
SATAKE, A ;
SAKURABA, H ;
SUZUKI, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :515-518
[9]   Fetal diagnosis of galactosialidosis (protective protein cathepsin A deficiency) [J].
Itoh, K ;
Miharu, N ;
Ohama, K ;
Mizoguchi, N ;
Sakura, N ;
Sakuraba, H .
CLINICA CHIMICA ACTA, 1997, 266 (02) :75-82
[10]  
ITOH K, 1993, J BIOL CHEM, V268, P1180